Financial Daily from THE HINDU group of publications
Friday, Apr 23, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Markets - Stock Markets


Dishman Pharma makes strong debut

Our Bureau

Mumbai , April 22

Dishman Pharmaceuticals and Chemicals Ltd made its debut on the Bombay Stock Exchange (BSE) at Rs 301.20 on Thursday.

By 3 p.m., the stock touched a high of Rs 593.70 and closed the first day of trading at Rs 542. Over 48 lakh shares were traded during the day on the BSE.

On the National Stock Exchange, the stock opened at Rs 345 and touched a high of Rs 597.80 before closing at Rs 513. Over 89 lakh shares were traded on the NSE.

The volumes across the two exchanges indicate that the total equity capital of the company was traded today. The total trading during the day is nearly four times the shares issued during the IPO.

"There is bound to be some volatility on the first day of trading. The price is also a reflection of the high levels of market interest in the pharmaceutical industry," said Mr Girish Nadkarni, Chief Operating Officer, IL&FS Investmart, one of the book running lead managers to the issue.

The Ahmedabad-based manufacturer of ammonium and phosphonium quaternary compounds had offered 34.3 lakh shares at Rs 175. The issue was oversubscribed by about 40 times.

More Stories on : Stock Markets

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Beep! Beep! It's your NAV


Tech funds regain lost ground
Bulls march ahead
Block deals in Vesuvius
Dishman Pharma makes strong debut
Institutional appeal
GAIL: Outlook positive, buy May futures
Cement, pharma, auto stocks prop up Sensex
Vishal Exports to tap capital market
Retail investors pick up less in ICICI Bank issue
Warburg relocates top brass to India



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line